南京地区肠内肠外营养药物利用研究

Study on the Utilization of Enteral and Parenteral Nutrition Drugs in Nanjing Area

目的:分析南京地区营养药物利用情况,为临床合理用药及企业生产药物提供参考。方法:提取2017~2021年南京地区35家样本医院的肠内外营养药物采购数据,分析营养药物采购金额、总热卡增长比例、年平均增长率、占比和排名等情况。结果:采购金额和总热卡年平均增长率均为肠内营养药物高于肠外营养药物。肠内外营养药物所占总采购金额构成比相对稳定,肠内营养药物约占30%,肠外营养药物约占70%。肠内营养药物以整蛋白类为主,肠外营养药物以氨基酸类为主。结论:2017~2021年南京地区营养药物采购金额和药物总热卡总体呈上升趋势,肠内营养药物增长更快。目前,南京地区临床营养药物治疗仍以肠外营养药物为主。

Objective:To analyze the utilization of nutritional drugs in Nanjing,to provide reference for the rational use of drugs in clinics and for the production of drugs by enterprises.Methods:Procurement data of enteral and parenteral nutritional drugs were extracted from 35 sample hospitals in Nanjing from 2017 to 2021,to analyze the procurement amount of nutritional drugs,the percentage of total calorie growth,the average annual growth rate,the percentage share and the ranking.Results:The average annual growth rates of the procurement amount and the total calories of enteral nutritional drugs were higher than those of parenteral nutritional drugs.The proportion of total procurement amount of enteral and parenteral nutrition drugs was relatively stable,with enteral nutrition drugs accounting for about 30%and parenteral nutrition drugs accounting for about 70%.Enteral nutrition drugs were mainly integrative proteins and parenteral nutrition drugs were mainly amino acids.Conclusion:Nutritional drug purchase amount and total drug calories in Nanjing from 2017 to 2021 are generally on the rise,and those for enteral nutrition drugs are growing even faster.At present,clinical nutritional drug treatment in Nanjing is still dominated by parenteral nutrition drugs.